HOUSTON – Bracewell LLP has announced that New York Office Managing Partner Daniel S. Connolly and Houston Partner Phillip L. Sampson Jr. have each been elected to serve a three-year term on Bracewell’s firm-wide management committee.
Connolly serves as managing partner of Bracewell’s New York office. As a litigator, his focus is on representing clients in such diverse industries as banking and pharmaceuticals in a wide spectrum of white collar defense and regulatory compliance investigations, as well as class action and complex commercial litigations.
In addition to representing clients in federal and New York State trial and appellate courts, Connolly regularly appears before federal departments and agencies, including the United States Department of Justice, the Securities and Exchange Commission, the Food and Drug Administration, and the Health and Human Services’ Office of Inspector General, as well as various state investigatory and enforcement agencies.
Sampson is a litigator with experience trying cases for both plaintiffs and defendants in state and federal courts, as well as before arbitration panels. Sampson’s litigation experience and jury verdict successes have involved both personal injury and commercial matters, and he has also successfully handled a number of appeals at the state and federal level. He represents clients in a diverse range of industries and matters, with a focus on complex commercial litigation and mass tort.
Sampson has prosecuted and defended cases involving complex contract and payment issues, trade secret and intellectual property rights, fraud, construction and products liability, consumer protection statutes, real estate and landlord/tenant issues, securities fraud, defamation, employment claims, insurance claims, and personal injury. He is currently trial counsel for plaintiffs in litigation involving the prescription drugs Depakote, Actos and Plavix, and the medical device Medtronic Infuse.